Anaplastic thyroid cancer, tumorigenesis and therapy

被引：0
|
作者：
J. P. O’Neill
D. Power
C. Condron
D. Bouchier-Hayes
M. Walsh
机构：
[1] The Royal College of Surgeons in Ireland,The Department of Otolaryngology
[2] Beaumont Hospital,Department of Oncology
[3] Memorial Sloan Kettering Cancer Center,The Department of Surgery
[4] The Royal College of Surgeons in Ireland,undefined
[5] Beaumont Hospital,undefined
来源：
Irish Journal of Medical Science | 2010年 / 179卷
关键词：
Anaplastic thyroid cancer; Undifferentiation; Post-malignant dedifferentiation; Oncogene; Radiotherapy; Surgery; Chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：9 / 15
页数：6
相关论文
共 50 条
  • [21] Cancer Stem Cells Markers in Human Thyroid Tumorigenesis: Role of p63 in Anaplastic Thyroid Carcinoma
    Laury, A. R.
    Nucera, C.
    Nose, V.
    MODERN PATHOLOGY, 2010, 23 : 129A - 129A
  • [22] Cancer Stem Cells Markers in Human Thyroid Tumorigenesis: Role of p63 in Anaplastic Thyroid Carcinoma
    Laury, A. R.
    Nucera, C.
    Nose, V.
    LABORATORY INVESTIGATION, 2010, 90 : 129A - 129A
  • [23] The genomic and transcriptomic landscape of anaplastic thyroid cancer: implications for therapy
    Katayoon Kasaian
    Sam M. Wiseman
    Blair A. Walker
    Jacqueline E. Schein
    Yongjun Zhao
    Martin Hirst
    Richard A. Moore
    Andrew J. Mungall
    Marco A. Marra
    Steven JM Jones
    BMC Cancer, 15
  • [24] Multimodal Therapy Improves Overall Survival in Anaplastic Thyroid Cancer
    Venkatramani, Mandakini
    Kuchta, Kristine
    Khokar, Amna
    Moo-Young, Tricia
    Prinz, Richard A.
    Winchester, David J.
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (SUPPL 2) : 437 - 437
  • [25] Quinacrine and sorafenib combination as potential therapy for anaplastic thyroid cancer
    Abdulghani, Junaid
    Gallant, Jean-Nicolas
    Whitcomb, Tiffany
    Dicker, David
    Smith, Charles D.
    Goldenberg, David
    El-Deiry, Wafik S.
    CANCER RESEARCH, 2012, 72
  • [26] Response to Targeted Therapy in BRAF Mutant Anaplastic Thyroid Cancer
    Agarwal, Rishi
    Wang, Jiang
    Wilson, Keith
    Barrett, William
    Morris, John C.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2016, 14 (10): : 1203 - 1207
  • [27] Combinatorial immune checkpoint inhibitor therapy in anaplastic thyroid cancer
    Chakraborty, Sanjukta
    Maniyar, Rachana R.
    Dadafarin, Sina
    Ben Rahoma, Ghada
    Singh, Sarnath
    Moscatello, Augustine
    Geliebter, Jan
    Tiwari, Raj K.
    CANCER RESEARCH, 2019, 79 (13)
  • [28] The genomic and transcriptomic landscape of anaplastic thyroid cancer: implications for therapy
    Kasaian, Katayoon
    Wiseman, Sam M.
    Walker, Blair A.
    Schein, Jacqueline E.
    Zhao, Yongjun
    Hirst, Martin
    Moore, Richard A.
    Mungall, Andrew J.
    Marra, Marco A.
    Jones, Steven J. M.
    BMC CANCER, 2015, 15
  • [29] Combination Therapy with Sorafenib and Vemurafenib Is Effective in Anaplastic Thyroid Cancer
    Shell, Jasmine
    Zhang, Lisa
    Zhang, Yaqin
    Shen, Min
    Boufraqech, Myriem
    Nilubol, Naris
    Patel, Dhaval
    Kebebew, Electron
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2016, 223 (04) : S45 - S45
  • [30] ANAPLASTIC THYROID CANCER 12 YEARS AFTER RADIOIODINE THERAPY
    BAKER, HW
    CANCER, 1969, 23 (04) : 885 - &
12345